Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China
· Delayed Price · Currency is CNY 6.46
+0.06 (0.94%)
At close: Mar 10, 2026
SHE:300039 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 345.55 | 375.58 | 327.87 | 190.8 | 140.11 | 106.12 | Upgrade
|
| Depreciation & Amortization | 35.42 | 35.42 | 37.53 | 31.71 | 33.86 | 40.81 | Upgrade
|
| Other Amortization | 0.93 | 0.93 | 0.11 | 0.01 | - | 0.21 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.26 | 0.26 | 0.21 | 0.17 | 0.22 | 0.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | -3.03 | -3.03 | 7.33 | 0.65 | -6.16 | -1.05 | Upgrade
|
| Loss (Gain) From Sale of Investments | -11.43 | -11.43 | -4.92 | 10.69 | 4.85 | 1.65 | Upgrade
|
| Other Operating Activities | -27.8 | -0.43 | -1.64 | -0.44 | -0.68 | 1.21 | Upgrade
|
| Change in Accounts Receivable | -0.14 | -0.14 | 99.53 | 58.32 | -74.9 | 137.88 | Upgrade
|
| Change in Inventory | -16.26 | -16.26 | -10.33 | 4.06 | 27.22 | -2.23 | Upgrade
|
| Change in Accounts Payable | -102.8 | -102.8 | -60.18 | 76.9 | -4.37 | -25.24 | Upgrade
|
| Change in Other Net Operating Assets | -4.32 | -4.32 | -5.33 | 6.8 | 3.33 | -2.18 | Upgrade
|
| Operating Cash Flow | 221.56 | 278.95 | 382.66 | 376.42 | 126.08 | 250.65 | Upgrade
|
| Operating Cash Flow Growth | -37.04% | -27.10% | 1.66% | 198.56% | -49.70% | -24.97% | Upgrade
|
| Capital Expenditures | -19.89 | -140.52 | -29.08 | -31.62 | -42.55 | -13.94 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.46 | 0.03 | 0.03 | 0.27 | 0.15 | 0.11 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -14.52 | -4.45 | Upgrade
|
| Investment in Securities | 62.26 | 90.73 | -181.21 | -257.11 | -29.93 | 69.34 | Upgrade
|
| Other Investing Activities | 129.87 | 16.33 | 11.63 | 3.08 | 3.34 | 14.3 | Upgrade
|
| Investing Cash Flow | 172.69 | -33.43 | -198.63 | -285.37 | -83.51 | 65.21 | Upgrade
|
| Short-Term Debt Issued | - | 5.42 | - | - | - | 35.72 | Upgrade
|
| Total Debt Issued | 2.43 | 5.42 | - | - | - | 35.72 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -37.72 | - | Upgrade
|
| Total Debt Repaid | - | - | - | - | -37.72 | - | Upgrade
|
| Net Debt Issued (Repaid) | 2.43 | 5.42 | - | - | -37.72 | 35.72 | Upgrade
|
| Common Dividends Paid | -104.64 | -104.6 | -62.76 | -52.3 | -31.64 | -104.6 | Upgrade
|
| Other Financing Activities | -0.05 | -0.05 | - | - | - | -0.52 | Upgrade
|
| Financing Cash Flow | -102.25 | -99.23 | -62.76 | -52.3 | -69.37 | -69.39 | Upgrade
|
| Net Cash Flow | 292 | 146.3 | 121.27 | 38.75 | -26.8 | 246.47 | Upgrade
|
| Free Cash Flow | 201.66 | 138.43 | 353.59 | 344.8 | 83.53 | 236.71 | Upgrade
|
| Free Cash Flow Growth | -0.06% | -60.85% | 2.55% | 312.79% | -64.71% | -25.71% | Upgrade
|
| Free Cash Flow Margin | 17.22% | 9.40% | 22.18% | 30.82% | 7.59% | 26.07% | Upgrade
|
| Free Cash Flow Per Share | 0.19 | 0.13 | 0.34 | 0.33 | 0.08 | 0.23 | Upgrade
|
| Cash Interest Paid | 0.04 | 0.04 | - | - | - | 0.52 | Upgrade
|
| Cash Income Tax Paid | 178.3 | 239.25 | 255.43 | 144.47 | 157.16 | 151.53 | Upgrade
|
| Levered Free Cash Flow | 171.41 | 15.38 | 261.78 | 275.04 | 16.78 | 191.45 | Upgrade
|
| Unlevered Free Cash Flow | 171.47 | 15.41 | 261.78 | 275.04 | 16.88 | 191.78 | Upgrade
|
| Change in Working Capital | -118.33 | -118.33 | 16.17 | 142.82 | -46.13 | 101.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.